Tal Golesworthy gave the closing speech at Medforce Europe in Hamburg on 6 June 2017. The subject of his talk was patient-driven innovation, with particular reference to the PEARS project. Medforce Europe is aimed at sales and marketing professionals working in the medical device industry and the event features senior speakers from industry-leading companies. For more information, visit medforceeu.wbresearch.com/.
At the London Bridge Hospital today, the 100th patient to receive the ExoVasc support was operated on successfully and now has their personalised external aortic root support in place to prevent further dilatation of their ascending aorta. Commenting on this milestone, Peter Gibson – CEO of Exstent Ltd – said: “It is encouraging now to see more centres adopting this new approach to the management of aortic dilatation. Patients have a right to be informed on all the options available in the surgical management of their condition, and for most of those aware of the PEARS approach this is their preferred option.”
Tal Golesworthy spoke at Healthcare Education and Research Talks (HEART) in Cluj Napoce, Romania. The title of his talk was How I repaired my own heart. HEART aims to fill in the gaps in medical curricula, providing students with inspiring mentors, motivating cutting edge technology and research information, problem-based learning and interprofessional collaboration. For more information, visit https://www.heartcluj.com.
On 29 March 2017, Tal Golesworthy and the PEARS project featured in the final episode of the BBC2 documentary series Incredible Medicine. In the series surgeon Gabriel Weston looked at the rare and extraordinary cases that are bringing new discoveries about the human body and leading to the medical cures of the future.
On 15 March Tal Golesworthy spoke at the Minds that Change the World conference at the Faculty of Medicine of Santiago de Compostela, Spain. Aimed at students, medical residents and doctors, the theme of the event was the application of technology to medicine where we combine both to change people’s lives and revolutionise health care. You can read more about the conference at www.cimq17.org.
Tal Golesworthy and the PEARS project is featured in a book and website called Healthcare Heroes: The Passion Project. The project is run by Havas Lynx, a leading global healthcare communications group, and it’s dedicated to the people working with passion, purpose and determination to improve peoples’ lives all over the world.
You can read Tal’s story on the Healthcare Heroes website.
Tal Golesworthy was a keynote speaker at the Research Strategy for Patient Oriented Research (SPOR) Summit, which took place in Ottawa, Canada between 25 and 27 October. The conference had the theme of Health Innovation: Working Together on Shared Health Priorities and brought together SPOR stakeholders, including patients, federal, provincial and territorial ministries, partners, researchers and clinicians. More information about SPOR can be found at www.cihr-irsc.gc.ca
Tal Golesworthy was a keynote speaker at BRAINCOMS, the Brazilian International Congress of Medical Students, which took place at the Escola Paulista de Medicina – Universidade Federal de São Paulo, Sao Paolo, Brazil between 20 and 22 October. The event gives delegates the opportunity to learn from internationally renowned keynote speakers, practise their skills in hands-on workshops and build up networks with other medical students from around the world. For more information on the conference visit www.braincoms.com.
At the invitation of cardiologist Prof Dr Jose Honorio Palma, Tal Golesworthy introduced PEARS to cardiac surgeons at the Instituto do Coração (InCor), which is part of the Hospital das Clínicas da Faculdade de Medicina at the University of São Paulo, Brazil.
In an editorial published today in the European Journal of Cardio-Thoracic Surgery, Leslie Hamilton – former president of the Society for Cardio-Thoracic Surgery in Great Britain and Ireland and regional director for professional affairs at the Royal College of Surgeons of England – discusses the question of when an emerging technology should enter the therapeutic arena. Commenting specifically on the Personalised External Aortic Root Support (PEARS) he argues that, following a precedent set in a recent Supreme Court case, surgeons have a responsibility to provide information on all appropriate medical procedures to allow the patient to make an informed decision. He suggests that patients should be made aware of the PEARS option. You can read the article here.